Bristol-Myers Squibb Company
Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors

Abstract:

The present invention provides compounds of Formula (I): ##STR00001## a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, a solvate thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.